• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Targeting the Subpocket Enables the Discovery of Thiadiazole-Pyridazine Derivatives as Glutaminase C Inhibitors.靶向亚口袋可发现噻二唑并哒嗪衍生物作为谷氨酰胺酶C抑制剂。
ACS Med Chem Lett. 2023 Sep 28;14(10):1455-1466. doi: 10.1021/acsmedchemlett.3c00375. eCollection 2023 Oct 12.
2
Characterization of the interactions of potent allosteric inhibitors with glutaminase C, a key enzyme in cancer cell glutamine metabolism.鉴定强效变构抑制剂与谷氨酰胺酶 C 的相互作用,谷氨酰胺酶 C 是癌细胞谷氨酰胺代谢中的关键酶。
J Biol Chem. 2018 Mar 9;293(10):3535-3545. doi: 10.1074/jbc.M117.810101. Epub 2018 Jan 9.
3
New insights into the molecular mechanisms of glutaminase C inhibitors in cancer cells using serial room temperature crystallography.利用连续室温晶体学技术深入研究谷氨酰胺酶 C 抑制剂在癌细胞中的分子机制。
J Biol Chem. 2022 Feb;298(2):101535. doi: 10.1016/j.jbc.2021.101535. Epub 2021 Dec 24.
4
The activation loop and substrate-binding cleft of glutaminase C are allosterically coupled.谷氨酰胺酶C的激活环与底物结合裂隙存在变构偶联。
J Biol Chem. 2020 Jan 31;295(5):1328-1337. doi: 10.1074/jbc.RA119.010314. Epub 2019 Dec 23.
5
Mechanism by which a recently discovered allosteric inhibitor blocks glutamine metabolism in transformed cells.一种最近发现的变构抑制剂阻断转化细胞中谷氨酰胺代谢的机制。
Proc Natl Acad Sci U S A. 2015 Jan 13;112(2):394-9. doi: 10.1073/pnas.1414056112. Epub 2014 Dec 29.
6
Mechanistic Basis of Glutaminase Activation: A KEY ENZYME THAT PROMOTES GLUTAMINE METABOLISM IN CANCER CELLS.谷氨酰胺酶激活的机制基础:一种促进癌细胞谷氨酰胺代谢的关键酶。
J Biol Chem. 2016 Sep 30;291(40):20900-20910. doi: 10.1074/jbc.M116.720268. Epub 2016 Aug 19.
7
Serial Room Temperature Crystal Loading, Data Collection, and Data Processing of Human Glutaminase C in Complex with Allosteric Inhibitors.人谷氨酰胺酶C与变构抑制剂复合物的系列室温晶体装载、数据收集及数据处理
Bio Protoc. 2022 Sep 20;12(18). doi: 10.21769/BioProtoc.4509.
8
High-resolution structures of mitochondrial glutaminase C tetramers indicate conformational changes upon phosphate binding.线粒体谷氨酰胺酶 C 四聚体的高分辨率结构表明在磷酸盐结合时构象发生变化。
J Biol Chem. 2022 Feb;298(2):101564. doi: 10.1016/j.jbc.2022.101564. Epub 2022 Jan 6.
9
Phosphorylation of glutaminase by PKCε is essential for its enzymatic activity and critically contributes to tumorigenesis.PKCε 对谷氨酰胺酶的磷酸化对于其酶活性是必不可少的,并且对肿瘤发生有重要贡献。
Cell Res. 2018 Jun;28(6):655-669. doi: 10.1038/s41422-018-0021-y. Epub 2018 Mar 7.
10
Conformational changes in the activation loop of mitochondrial glutaminase C: A direct fluorescence readout that distinguishes the binding of allosteric inhibitors from activators.线粒体谷氨酰胺酶C激活环中的构象变化:一种直接荧光读数,可区分变构抑制剂与激活剂的结合。
J Biol Chem. 2017 Apr 14;292(15):6095-6107. doi: 10.1074/jbc.M116.758219. Epub 2017 Feb 14.

本文引用的文献

1
Synthesis of Novel Kidney-Type Glutaminase Allosteric Inhibitors Targeting the Critical Lys-320 Residue.靶向关键赖氨酸-320残基的新型肾型谷氨酰胺酶变构抑制剂的合成
ACS Med Chem Lett. 2022 Dec 22;14(1):11-17. doi: 10.1021/acsmedchemlett.2c00302. eCollection 2023 Jan 12.
2
Structure-Enabled Discovery of Novel Macrocyclic Inhibitors Targeting Glutaminase 1 Allosteric Binding Site.结构导向的新型大环抑制剂的发现,靶向谷氨酰胺酶 1 变构结合位点。
J Med Chem. 2021 Apr 22;64(8):4588-4611. doi: 10.1021/acs.jmedchem.0c02044. Epub 2021 Apr 1.
3
Discovery of IPN60090, a Clinical Stage Selective Glutaminase-1 (GLS-1) Inhibitor with Excellent Pharmacokinetic and Physicochemical Properties.发现 IPN60090,一种临床阶段的选择性谷氨酰胺酶-1(GLS-1)抑制剂,具有优异的药代动力学和物理化学性质。
J Med Chem. 2020 Nov 12;63(21):12957-12977. doi: 10.1021/acs.jmedchem.0c01398. Epub 2020 Oct 29.
4
Discovery of a Thiadiazole-Pyridazine-Based Allosteric Glutaminase 1 Inhibitor Series That Demonstrates Oral Bioavailability and Activity in Tumor Xenograft Models.发现基于噻二唑-哒嗪的变构谷氨酰胺酶 1 抑制剂系列,具有口服生物利用度,并在肿瘤异种移植模型中显示出活性。
J Med Chem. 2019 Jul 25;62(14):6540-6560. doi: 10.1021/acs.jmedchem.9b00260. Epub 2019 Jul 16.
5
Overview of the Development of Glutaminase Inhibitors: Achievements and Future Directions.谷氨酰胺酶抑制剂的发展概述:成就与未来方向。
J Med Chem. 2019 Feb 14;62(3):1096-1115. doi: 10.1021/acs.jmedchem.8b00961. Epub 2018 Sep 7.
6
Design, Synthesis, and Evaluation of Thiazolidine-2,4-dione Derivatives as a Novel Class of Glutaminase Inhibitors.设计、合成及噻唑烷-2,4-二酮衍生物作为新型谷氨酰胺酶抑制剂的评价。
J Med Chem. 2017 Jul 13;60(13):5599-5612. doi: 10.1021/acs.jmedchem.7b00282. Epub 2017 Jun 29.
7
A tale of two glutaminases: homologous enzymes with distinct roles in tumorigenesis.两种谷氨酰胺酶的故事:在肿瘤发生中具有不同作用的同源酶
Future Med Chem. 2017 Jan;9(2):223-243. doi: 10.4155/fmc-2016-0190. Epub 2017 Jan 23.
8
Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer.谷氨酰胺酶抑制剂CB-839在三阴性乳腺癌中的抗肿瘤活性。
Mol Cancer Ther. 2014 Apr;13(4):890-901. doi: 10.1158/1535-7163.MCT-13-0870. Epub 2014 Feb 12.
9
Glutamine and cancer: cell biology, physiology, and clinical opportunities.谷氨酰胺与癌症:细胞生物学、生理学和临床机遇。
J Clin Invest. 2013 Sep;123(9):3678-84. doi: 10.1172/JCI69600. Epub 2013 Sep 3.
10
Full-length human glutaminase in complex with an allosteric inhibitor.全长人谷氨酰胺酶与别构抑制剂复合物。
Biochemistry. 2011 Dec 20;50(50):10764-70. doi: 10.1021/bi201613d. Epub 2011 Nov 18.

靶向亚口袋可发现噻二唑并哒嗪衍生物作为谷氨酰胺酶C抑制剂。

Targeting the Subpocket Enables the Discovery of Thiadiazole-Pyridazine Derivatives as Glutaminase C Inhibitors.

作者信息

Sun Hanyu, Du Tingting, Yang Minjian, Liu Xue, Xue Xi, Chen Kai, Lang Xuli, Chen Xiaoguang, Wang Baolian, Wang Xiaojian

机构信息

State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100050, P. R. China.

Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation, Department of Medicinal Chemistry, Institute of Materia Medica, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100050, P. R. China.

出版信息

ACS Med Chem Lett. 2023 Sep 28;14(10):1455-1466. doi: 10.1021/acsmedchemlett.3c00375. eCollection 2023 Oct 12.

DOI:10.1021/acsmedchemlett.3c00375
PMID:37849538
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10577699/
Abstract

As glutaminase C (GAC) has become an attractive target for cancer treatment by regulating glutaminolysis, thus, interest in GAC inhibitors has risen in recent years. Herein, a potential binding subpocket comprising basic residues was identified, and through extensive structure-activity relationship studies, promising inhibitors and were identified with robust GAC inhibitory activity and A549 cell antiproliferative activity. X-ray crystallography of the -GAC and -GAC complexes revealed a novel binding mode against GAC. The potency of and against GAC further highlighted the importance of the binding. Notably, compounds and regulated the cellular metabolite, thereby increasing reactive oxygen species by blocking glutamine metabolism. Compound also exhibited excellent antiproliferative activity in the A549 cell xenograft model. We further proved that is a safe GAC allosteric inhibitor. A basic subpocket is proposed that might provide new strategies for the development of novel GAC inhibitors in the future.

摘要

由于谷氨酰胺酶C(GAC)通过调节谷氨酰胺分解已成为癌症治疗的一个有吸引力的靶点,因此近年来对GAC抑制剂的兴趣有所增加。在此,鉴定出了一个包含碱性残基的潜在结合亚口袋,并通过广泛的构效关系研究,鉴定出了具有强大GAC抑制活性和A549细胞抗增殖活性的有前景的抑制剂。-GAC和-GAC复合物的X射线晶体学揭示了一种针对GAC的新型结合模式。和对GAC的效力进一步突出了这种结合的重要性。值得注意的是,化合物和调节细胞代谢物,从而通过阻断谷氨酰胺代谢增加活性氧。化合物在A549细胞异种移植模型中也表现出优异的抗增殖活性。我们进一步证明是一种安全的GAC变构抑制剂。提出了一个碱性亚口袋,这可能为未来新型GAC抑制剂的开发提供新策略。